New breast cancer drug better than tamoxifen: doctors
304755
TORONTO - A standard treatment used to prevent the recurrence of breast cancer should be replaced by a newer drug, according to a study released Wednesday.
139693
Postmenopausal women with early breast cancer who take tamoxifen for five years appear to have a 30 percent lower risk of dying from coronary heart disease than
507184
Women with breast cancer who take tamoxifen are less likely to have a heart attack than women with other types of cancer who are not taking the drug, according to a new report.
769714
A drug called anastrozole is better at preventing relapses among certain breast cancer patients than tamoxifen, the current standard treatment, research presented at a medical conference Wednesday shows.
702144
Taking tamoxifen to treat breast cancer won&#39;t increase your risk of stroke. However, a report on that finding, which appears in the Oct. 20 issue of the
742628
A fast-acting pathway used by the drug tamoxifen to kill damaged breast cells before they become cancerous has been identified by scientists at Duke University.
156055
TUESDAY, Feb. 13 (HealthDay News) -- Switching to newer breast cancer drugs, called aromatase inhibitors, after two to three years of treatment with tamoxifen may extend disease-free survival and slightly reduce the risk of death in women who've been treated for early stage disease, an international study finds.
668672
MONDAY, Feb. 26 (HealthDay News) -- Breast cancer treatment trials that are funded by drug companies are more likely to show positive results than studies sponsored by other sources, new research suggests.
229575
Breast cancer studies funded by drug companies are more likely to yield positive findings than those without pharmaceutical industry backing, according to research published on Monday.
43000
A class of hormone-blocking drugs called aromatase inhibitors was more effective in preventing breast cancer recurrence in women past menopause than was tamoxifen, a medication now prescribed
423651
FRIDAY, Nov. 17 (HealthDay News) -- Certain breast cancer patients who switch to the aromatase inhibitor drug anastrozole (Arimidex) after two to three years of treatment with tamoxifen live longer and are more likely to remain cancer-free, German researchers report.
339099
New data, from the landmark ATAC (âArimidex&#39;, Tamoxifen, Alone or in Combination) trial, is presented today at the San Antonio Breast Cancer Symposium, USA.
310366
San Antonio - A newer drug clearly outperforms tamoxifen at preventing breast cancer from returning and should become the first-choice treatment for most women who have had the disease, doctors are reporting.
195956
A newer drug prevented far more breast cancers from recurring in older women than the old standby tamoxifen and with far fewer side effects, doctors said Wednesday, citing a new study.
233800
New research shows that a set of simple questions may help primary-care practitioners identify which women would benefit from a more elaborate discussion of tamoxifen, a drug that can help prevent breast cancer.
516134
A new blood test holds promise for improving the treatment of advanced breast cancer, researchers report. The test, which looks for malignant cells in the blood, gives
228850
Older women with early breast cancer should take a new drug to cut the chance of the disease returning and spreading, it is claimed.